scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Craig Hallum from $16.00 to $12.00. They now have a "buy" rating on the stock.
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024